NG
NVAX icon

NatWest Group’s Novavax NVAX Stock Holding History

NatWest Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,021
Closed -$710K – 273
2015
Q3 		$710K Buy
+5,021
New +$1.13M 0.02% 227
2015
Q2 		– Sell
-5,021
Closed -$831K – 414
2015
Q1 		$831K Buy
+5,021
New +$815K 0.01% 244

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NatWest Group's NVAX Position: Q4 2015 in Review

NatWest Group sold out of Novavax (NVAX) in Q4 2015, closing a stake of 5,021 shares — an estimated $710K sold.

NatWest Group first reported a position in NVAX in Q1 2015 and held it in 2 quarters. The position peaked at $831K in Q1 2015. 173 funds tracked by Wall St. Rank hold NVAX as of Q4 2015.

  • NatWest Group reported no remaining Novavax position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 5,021 Novavax shares in Q4 2015, an estimated $710K.
  • NatWest Group first reported a position in Novavax in Q1 2015 and held it in 2 quarters.
  • NatWest Group's Novavax position peaked at $831K in Q1 2015.
  • 173 funds tracked by Wall St. Rank held Novavax as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.